C-reactive protein, renal function, and cardiovascular outcome in patients with symptomatic peripheral artery disease and preserved left ventricular systolic function

Croatian Medical Journal

Volumn 56, Issue 4, 2015, Pages 351-356

  Vrsalović, Mislav ^a,b   Vučur, Ksenija ^c   Car, Boris ^b   Krčmar, Tomislav ^b   Presečki, Ana Vrsalović ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c Institute for Emergency Medicine of the City of Zagreb   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANEMIA; ANKLE BRACHIAL INDEX; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CRITICAL LIMB ISCHEMIA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL; BLOOD; COMPLICATION; ECHOCARDIOGRAPHY; KIDNEY; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; STROKE;

AGED; C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; VENTRICULAR FUNCTION, LEFT;

EID: 84941202699     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2015.56.351     Document Type: Article

References (21)

1. Scirica BM, Morrow DA, Cannon CP, de Lemos JA, Murphy S, Sabatine MS, et al. Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clin Chem. 2007;53:1800-7. Medline:17717132 doi: 10.1373/clinchem.2007.087957
2. Owens CD, Kim JM, Hevelone ND, Gasper WJ, Belkin M, Creager MA, et al. An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease. J Vasc Surg. 2012;56:686-95. Medline:22554422 doi: 10.1016/j.jvs.2012.02.034
3. Schlager O, Amighi J, Haumer M, Sabeti S, Dick P, Mlekusch W, et al. Inflammation and adverse cardiovascular outcome in patients with renal artery stenosis and peripheral artery disease. Atherosclerosis. 2009;205:314-8. Medline:19152915 doi: 10.1016/j. atherosclerosis.2008.12.022
4. Brevetti G, Schiano V, Laurenzano E, Giugliano G, Petretta M, Scopacasa F, et al. Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. Eur Heart J. 2008;29:224-30. Medline:18156137 doi: 10.1093/eurheartj/ehm587
5. Criqui MH, Ho LA, Denenberg JO, Ridker PM, Wassel CL, McDermott MM. Biomarkers in peripheral arterial disease patients and near- and longer-term mortality. J Vasc Surg. 2010;52:85-90. Medline:20471776 doi: 10.1016/j.jvs.2010.02.004
6. Garimella PS, Hirsch AT. Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes. Adv Chronic Kidney Dis. 2014;21:460-71. Medline:25443571 doi: 10.1053/j. ackd.2014.07.005
7. Sefer S, Trotic R, Degoricija V, Vrsalovic M, Ratkovic-Gusic I, Kes P. Healing of skin necrosis and regression of anticardiolipin antibodies achieved by parathyroidectomy in a dialyzed woman with calcific uremic arteriolopathy. Croat Med J. 2001;42:679-82. Medline:11740855
8. Ward RP, Goonewardena SN, Lammertin G, Lang RM. Comparison of the frequency of abnormal cardiac findings by echocardiography in patients with and without peripheral arterial disease. Am J Cardiol. 2007;99:499-503. Medline:17293193 doi: 10.1016/j.amjcard.2006.09.102
9. Hedberg P, Hammar C, Selmeryd J, Viklund J, Leppert J, Hellberg A, et al. Left ventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: prevalence and association with location of arterial disease. Eur J Heart Fail. 2014;16:625-32. Medline:24771615 doi: 10.1002/ejhf.95
10. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851-906. Medline:21873417 doi: 10.1093/eurheartj/ehr211
11. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. Catheter Cardiovasc Interv. 2012;79:501-31. Medline:21960485 doi: 10.1002/ccd.23373
12. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press. 2014;23:3-16. Medline:24359485 doi: 10.3109/08037051.2014.868629
13. World Health Organization. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5-37. Medline:4975372
14. Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E, et al. Non-coronary atherosclerosis. Eur Heart J. 2014;35:1112-9. Medline:24595865 doi: 10.1093/eurheartj/ehu071
15. Vrsalovic M, Pintaric H, Babic Z, Pavlov M, Vrsalovic Presecki A, Getaldic B. at al. Impact of admission anemia, C-reactive protein and mean platelet volume on short term mortality in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Clin Biochem. 2012;45:1506-9. Medline:22659059 doi: 10.1016/j.clinbiochem.2012.05.026
16. Vrsalovic M, Zeljkovic I, Presecki AV, Pintaric H, Kruslin B. C-reactive protein, not cardiac troponin T, improves risk prediction in hypertensives with type A aortic dissection. Blood Press. 2015;24:212-6. Medline:25936403 doi: 10.3109/08037051.2015.1025607
17. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974-80. Medline:12186803 doi: 10.1161/01. CIR.0000027560.41358.B3
18. Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003;42:1535-43. Medline:14607434 doi: 10.1016/j.jacc.2003.06.001
19. Mlekusch W, Exner M, Sabeti S, Amighi J, Schlager O, Wagner O, et al. Serum creatinine predicts mortality in patients with peripheral artery disease: influence of diabetes and hypertension. Atherosclerosis. 2004;175:361-7. Medline:15262193 doi: 10.1016/j. atherosclerosis.2004.04.008
20. Van Kuijk JP, Flu WJ, Welten GM, Hoeks SE, Chonchol M, Vidakovic R, et al. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. Eur Heart J. 2010;31:992-9. Medline:20037181 doi: 10.1093/eurheartj/ehp553
21. Suárez C, Zeymer U, Limbourg T, Baumgartner I, Cacoub P, Poldermans D, et al. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry. Vasc Med. 2010;15:259-65. Medline:20724374 doi: 10.1177/1358863X10373299